Neste Jacobs playing a major role in Asia's largest biopharma project
(Thomson Reuters ONE) -
Neste Jacobs
Press Release
29, June 2016 at 10 (EET)
Neste Jacobs playing a major role in Asia's largest biopharma project
Technology, engineering and project management company Neste Jacobs has worked
on an assignment to prepare conceptual and basic design for Asia's largest human
blood plasma fractionation plant project.
These phases of the project are now successfully completed to enable the
implementation of the project by Sichuan Yuanda Shuyang Pharmaceutical Company.
Neste Jacobs has accumulated vast experience in human plasma fractionation over
the last 40 years and the company has in-depth understanding of plasma
technologies, production processes, operational aspects and cost levels required
for a fully functional human plasma fractionation plant. This highly regulated
biopharmaceutical sector sets high standards for the design and operation of the
facility. Product safety, regulatory compliance, traceability and robust
operability must be built-in during all design steps starting from conceptual
and basic design now completed by Neste Jacobs.
"This project demonstrates that we are the world's leading expert in this very
demanding bioindustry field", says Neste Jacobs CEO, Jarmo Suominen. "We have
thorough understanding of various blood plasma technologies and a comprehensive
network of partnerships in this field taking us way beyond our competition."
The plant now goes to the implementation phase, being built in China. "During
the conceptual and basic phases of this project we have greatly contributed to
our customer quality and functionality of the plant.
Our approach integrates technology, concepts and process knowledge within the
automated operations and constructability. This way our customers can be
confident about the functionality of the as such complex plasma fractionation
plant", says Neste Jacobs Bioindustries Sales Director, Kari Kaskes. "We are
without doubt a number one company in front line development of global
bioindustries."
Read more about Neste Jacobs' Biopharma expertise at
http://www.nestejacobs.com/industries/biopharma/
For more information, please contact:
Jarmo Suominen, CEO, Neste Jacobs Oy, tel. +358 50 458 3399
Kari Kaskes, Sales Director, Bioindustries, Neste Jacobs Oy, tel. +
358 50 458 9603
Neste Jacobs is a preferred solution provider of high-quality technology,
engineering and project services for a wide range of industries in the fields of
oil and gas, petrochemicals, chemicals, biorefining, biochemicals, biopharma and
industrial infrastructure. We have 60 years of experience in technology
development and industrial investment projects as well as maintenance and
performance improvement in Europe, North and South America, Asia and the Middle
East. In addition to our home market Nordic countries we are looking to grow in
the global expanding markets. We employ 1300 professionals globally.
www.nestejacobs.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Neste Oyj via GlobeNewswire
[HUG#2023616]
Unternehmensinformation / Kurzprofil:
Datum: 29.06.2016 - 09:00 Uhr
Sprache: Deutsch
News-ID 480586
Anzahl Zeichen: 3799
contact information:
Town:
Espoo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 279 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Neste Jacobs playing a major role in Asia's largest biopharma project"
steht unter der journalistisch-redaktionellen Verantwortung von
Neste Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
